key: cord-1056370-yb5fw68f
authors: Lao, Yongfeng; Jiang, Yanbiao; Luo, Xiao; Liu, Xiaolin
title: Focus on the depressive symptoms in COVID-19 patients: perspective based on a rapid meta-analysis
date: 2020-09-15
journal: Asian J Psychiatr
DOI: 10.1016/j.ajp.2020.102421
sha: e8993862bdc7794a940be44ad882118f05b74607
doc_id: 1056370
cord_uid: yb5fw68f

nan

Please cite this article as: Lao Y, Jiang Y, Luo X, Liu X, Focus on the depressive symptoms in COVID-19 patients: perspective based on a rapid meta-analysis, Asian Journal of Psychiatry (2020), doi: https://doi.org/10. 1016/j.ajp.2020.102421 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Since the end of 2019, Corona Virus Disease 2019 (COVID-19) has caused a worldwide pandemic. One study had found significant psychological distress even after hospital discharge in patients infected with severe acute respiratory syndrome (SARS) (Cheng et al. 2004) , indicating that the mental status of COVID-19 patients shouldn't be ignored as well. Actually, a "tsunami of psychiatric illness" is being predicted and actions such as calling for a special research topic and accelerating the manuscript review process have been taken to deal with the lacking of useful information in the mental health crisis(Tandon 2020). Though some studies assessed the prevalence of depressive symptoms and potential influencing factors in hospitalized (Ma et al. 2020) and discharged ) COVID-19 patients, these results might be misleading due to limited sample size. Thus, in this letter, we aimed to provide a rapid metaanalysis of the prevalence of depressive symptoms in COVID-19 patients and potential factors based on published studies which might be the reference for mental health intervention during the epidemic.

We searched PubMed, EMBASE, and Cochrane Library using the following keywords J o u r n a l P r e -p r o o f from inception to July 30, 2020: "depression", "depressive", "COVID-19", "2019nCoV" and "novel coronavirus" etc. Studies were included if: (1) all participants were diagnosed with COVID-19; (2) prevalence rates of depressive symptoms or related influencing factors with adjusted odds ratio (OR) and 95% confidence interval (CI) were reported; (3) depressive symptoms occurred after the diagnosis of (4) published in English in a peer-reviewed journal. In case of multiple publications on a single data set, the study with the largest sample size was included. Paired reviewers selected the articles and extracted data independently and then cross-checked. Any dispute was resolved by consensus. The prevalence of depressive symptoms was pooled using a random-effect model. Sensitivity analysis was conducted by excluding each study one by one and then the primary results were recalculated. Subgroup analysis was conducted based on whether to be discharged from the hospital and severity of depressive symptoms. I 2 was used to evaluate the heterogeneity between studies. ORs with their 95%CI of the same influencing factors were also pooled using random-effect model.

Eight cross-sectional studies were included after selection involving 2206 individuals with 1040 cases with depressive symptoms (Guo et al. 2020; Hu et al. 2020; Liguori et al. 2020; Liu et al. 2020; Ma et al. 2020; Nie et al. 2020; Yuan et al. 2020; ), among which two studies considered cured patients discharged from the hospital Yuan et al. 2020) . One study (Liguori et al. 2020 ) came from Italy while the others were all from China. As for diagnostic criteria of depressive symptoms, four studies used Patient Health Questionnaire (9-item version, PHQ-9) or its Chinese version Guo et al. 2020; Hu et al. 2020; Ma et al. 2020) , two studies used Zung Self-rating Depression Scale (SDS) (Nie et al. 2020; Yuan et al. 2020) , one study used the Chinese version of Hospital Anxiety and Depression Scale (HADS)(Zhang et al. 2020), and one study didn't report specific scale (Liguori et al. 2020 ).

The total prevalence of depressive symptoms in COVID-19 patients was 44% (95%CI, J o u r n a l P r e -p r o o f 30%-70%; I 2 =97.5%). Subgroup analysis presented that the prevalence of depressive symptoms in hospitalized and discharged patients were: 40% (95%CI, 28%-52%; I 2 =95.2%), and 55% (95%CI, 34%-77%; I 2 =93.9%) (Fig. 1) respectively. Sensitivity analysis when excluding each study one by one still showed a significantly high heterogeneity between the pooled studies. Subgroup analysis based on the depression severity showed a decreasing trend of prevalence that was 31% (95%CI: 19%-43%; I 2 =95.9%) for mild, 13% (95%CI: 11%-15%; I 2 =0%) for moderate, and 5% (95%CI: 2%-8%; I 2 =74.3%) for severe, respectively (Supplementary Table S1 ). As there were less than ten studies, publication bias analysis or meta-regression were not conducted.

We summarized the potential influencing factors reported in included studies in Supplementary Table S2 . Meta-analysis was conducted for factors that were reported twice at least. For factors after meta-analysis, only family members diagnosed with COVID-19 (RR=1.35, 95%CI:1.00-1.84, P=0.051) and higher disease severity (RR=2.68, 95%CI: 1.04-6.91, P=0.042) might be correlated with depressive symptoms.

Factors reported in single study such as smoke, more clinical symptoms after discharge, and perceived discrimination might be risk factors while frequent social media use and high level of resilience might be protective factors (Supplementary Table S2 ).

In this study, we firstly reported the pooled prevalence of depressive symptoms and potential influencing factors in COVID-19 patients. Highly elevated prevalence of depressive symptoms was found in COVID-19 patients not only when treated in hospital but also after hospital discharge, in which a considerable part appeared severe symptoms. Our results highlight an urgent need for psychological support and counseling for COVID-19 patients in the pandemic of the world although most of the research originated from China associated with significant heterogeneity. In fact, the

Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS)

Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study

Factors related to mental health of inpatients with COVID-19 in Wuhan, China

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection

Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China

Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19

Anxiety and depression and its correlates in patients with coronavirus disease 2019 in Wuhan